<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01553890</url>
  </required_header>
  <id_info>
    <org_study_id>vitamin D and Scleroderma</org_study_id>
    <nct_id>NCT01553890</nct_id>
  </id_info>
  <brief_title>Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy Peoples</brief_title>
  <acronym>SSc</acronym>
  <official_title>Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at SSc Patients Compared Healthy Peoples</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to find the presence of anti vitamin D antibodies in scleroderma patients and
      compare with control. A second goal is anti vitamin D levels in serum of scleroderma patients
      in relation to the clinical manifestations of the disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood samples from 30 scleroderma patients compared to 30 healthy peoples to reach the target
      of variation of the blood level vitamin D antibody between this groups
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of anti vitamin D antibodies in scleroderma patients compared with control</measure>
    <time_frame>March 2013 (up to one year)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anti vitamin D presence and levels in serum in relation to the clinical manifestations of scleroderma</measure>
    <time_frame>March 2013 (up to one year)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Scleroderma</condition>
  <arm_group>
    <arm_group_label>Patients diagnosed with scleroderma</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients diagnosed with scleroderma, clinical and lab support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No disease</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Blood sample, venous blood, about 10 ml will be drawn from participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>blood sample, venous blood, about 10 ml will be drawn from participants</description>
    <arm_group_label>Patients diagnosed with scleroderma</arm_group_label>
    <arm_group_label>No disease</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        study group

          1. patients with SSc

          2. age - 18 years old and older

          3. sign ICF control group - healthy people
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2012</study_first_posted>
  <last_update_submitted>March 13, 2012</last_update_submitted>
  <last_update_submitted_qc>March 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SSc= scleroderma</keyword>
  <keyword>ICF+ informed consent form</keyword>
  <keyword>age 18 to 85</keyword>
  <keyword>healthy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
    <mesh_term>Scleroderma, Localized</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

